In our current study, we verified that miR-16 is decreased in NPC and that miR-16 targets FGF2 to inhibit NPC cell proliferation and invasion via the MAPK and PI3K/AKT signaling pathways. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.